Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Strategy (STRF) Research & Development (2016 - 2026)

Strategy has reported Research & Development over the past 17 years, most recently at $24.7 million for Q1 2026.

  • Quarterly results put Research & Development at $24.7 million for Q1 2026, up 0.99% from a year ago — trailing twelve months through Mar 2026 was $94.1 million (down 17.26% YoY), and the annual figure for FY2025 was $93.9 million, down 20.78%.
  • Research & Development reached $24.7 million in Q1 2026 per STRF's latest filing, up from $22.8 million in the prior quarter.
  • Across five years, Research & Development topped out at $33.5 million in Q1 2022 and bottomed at $22.6 million in Q3 2025.
  • Median Research & Development over the past 5 years was $29.7 million (2023), compared with a mean of $28.5 million.
  • The largest annual shift saw Research & Development grew 13.7% in 2022 before it tumbled 32.13% in 2025.
  • Over 5 years, Research & Development stood at $31.6 million in 2022, then decreased by 4.61% to $30.2 million in 2023, then fell by 14.81% to $25.7 million in 2024, then decreased by 11.39% to $22.8 million in 2025, then increased by 8.35% to $24.7 million in 2026.
  • Business Quant data shows Research & Development for STRF at $24.7 million in Q1 2026, $22.8 million in Q4 2025, and $22.6 million in Q3 2025.